SCHEMBL32688028

SCHEMBL32688028

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1ccccc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 7/20 0.47
▸ HSD11B2 P80365 1/20 0.45
▸ ACMSD Q8TDX5 1/20 0.40
▸ POLB P06746 4/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ CXCR2 P25025 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ PDE9A O76083 1/20 0.38
▸ BIRC5 O15392 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TNF P01375 1/20 0.37
▸ PLA2G1B P04054 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.37
▸ ATG4B Q9Y4P1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688250 0.93 HSD11B1 (0.41) HSD11B1HSD11B2ACMSDPOLBMEN1
SCHEMBL32688115 0.90 HPGD (0.41) HSD11B1HSD11B2MEN1KMT2ACXCR2
SCHEMBL32688147 0.90 HSD11B1 (0.40) HSD11B1HSD11B2POLBMEN1KMT2A
SCHEMBL32688008 0.90 MEN1 (0.42) HSD11B1HSD11B2ACMSDPOLBMEN1
SCHEMBL32688050 0.87 HSD11B1 (0.44) HSD11B1HSD11B2POLBCXCR2BRD4
SCHEMBL32688370 0.87 POLB (0.41) HSD11B1HSD11B2ACMSDPOLBMEN1
SCHEMBL32688269 0.81 HSD11B1 (0.45) HSD11B1ACMSDPOLBMEN1KMT2A
SCHEMBL32688201 0.81 HSD11B1 (0.36) HSD11B1HSD11B2CXCR2PDE9A
SCHEMBL32688166 0.81 HSD11B1 (0.41) HSD11B1HSD11B2MEN1KMT2APDE9A
SCHEMBL32688034 0.80 PDE9A (0.43) POLBMEN1KMT2ACXCR2PDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885HSD11B2 131/4885ACMSD 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback